baber/WOPTO huggingface dataset:
Patent NZ-336797-A (NZ)
Title: Computer executable workflow resource management system
Inventor: TURLEY WILLIAM N
IPC: G06Q10/10
Filed: 1997-12-18
Abstract: A computer system executable method is provided for managing resources in an automated workflow system for manipulating a work item, the work item being stored in a database of work items for subsequent execution by an operator and meeting a predetermined criteria. A first definitional data item is stored in a memory, the first definitional data item affecting how the workflow system processes work items meeting the predetermined criteria. A directive is received from an administrator to remove the first definitional data item from the memory. A mark is set, the mark being associated with the first definitional data item to indicate that the first definitional data item is to be removed from the memory. If a second definitional data item is normally able to be made dependent on the first definitional data item, the mark is used to prevent the second definitional data item from being made dependent on the first definitional data item after the mark was set. The mark is used to prevent the first definitional data item from affecting another work item if the other work item failed to meet the predetermined criteria until after the mark was set. The work item is processed until the work item no longer meets the predetermined criteria. It is determined whether any other definitional data items are dependent on the first definitional data item. Depending on the outcome of the determination, the first definitional data item is removed from the memory.
Patent NZ-338000-A (NZ)
Title: Bacterial plasmids, pMUT1 and pMUT2 and their use in a medicament.
Inventor: HACKER JORG
IPC: A23L33/00
Filed: 1998-04-01
Abstract: Disclosed is the above pMUT1 plasmid and it's use in the diagnosis of illnesses involving Enterobacteria.  The plasmid is also used as a composition for nutritional, physiological, medicinal and probiotic purposes.
Patent NZ-502043-A (NZ)
Title: Ultra-high-strength low-alloy steel container for transport and storage of pressurized liquefied natural gas
Inventor: BOWEN RONALD R
IPC: F25B19/00
Filed: 1998-06-18
Abstract: A tanker truck container for the transport and storage for pressurized liquefied natural gas at a pressure of between 1035 kPa and 7590 kPa and at a temperature between -123 degrees Celsius and -62 degrees Celsius, includes an inner vessel 11 constructed by welding together a plurality of discrete plates of ultra high strength low alloy steel containing less than 9 wt% nickel and having a tensile strength greater than 830 MPa.  The steel is tough at cryogenic temperatures, having a Ductile to Brittle Transition Temperature (DBTT) less than -73 degrees Celsius.  The welded joints have about the same toughness as the plates and a strength of about 90% of that of the plates, sufficient to contain the pressurized liquefied natural gas without leakage under the severe pressure and temperature conditions.   The inner vessel may be suspended within an outer vessel 13 for thermal insulation and shock absorption.
Patent NZ-504346-A (NZ)
Title: Process for the synthesis of 1,3-diols characterised by either reconcentration step with either trialkylborane or dialkylalkoxyborane or a mixture of both trialkylborane and dialkylalkoxyborane
Inventor: MCCABE RICHARD JOSEPH
IPC: C07D207/416
Filed: 1998-12-02
Abstract: A process for the preparation of cis-1,3-diols such as shown by general Formula (I). The process is characterised by a beta hydroxy ketone is treated with a trialkylborane as shown by Formula (XII) or dialkylborane as shown by the Formula (XIII) or a mixture thereof followed by a recovery and reused of the alkylborane species to convert additional beta hydroxy ketone to the cis-1,3-diol. Wherein; R is alkyl, NC-CH2-, PG-O-CH2- wherein PG is a protecting group, Formula (II), Formula (III), Formula (IV) wherein R2 is (H3C)2CH- or cyclopropyl, Formula (V) wherein R3is C6H5, (H3C)2N- or (H3C)2CH-; R4 is hydrogen, H3COCH2-, H3CCH2C(CH3)2CO2CH2- or H3CO2CCH2CH(OH)CH2CH(OH)CH=CH-, Formula (VI), Formula (VII), Formula (VIII) wherein R5 is Formula (a), Formula (b) or Formula I(c) wherein R6, R7 and R9 is hydrogen or CH3, R8 is hydrogen, OH, CH3 or H5C6NHCOO-, Formula (IX), Formula (X), Formula (XI); R1 is alkyl or -CH2CO2R6 wherein R6 is alkyl.
Patent NZ-505305-A (NZ)
Title: Antigen binding fragments that inhibit an antibody comprising amino acid sequences of H and L chain V regions of a scFv from binding to the surface of a cancer cell
Inventor: DANN MICHAEL D
IPC: C07K16/30
Filed: 1997-05-22
Abstract: Described is the monoclonal antibody H11 and antigen binding fragments that specifically bind to the antigen recognized by H11, the C-antigen.  The C-antigen is found specifically on neoplastic cells and not on normal cells.  Also disclosed are polynucleotide and polypeptide derivatives based on H11, including single chain V region molecules and fusion proteins, and various pharmaceutical compositions.  When administered to an individual, the H11 antibody is effective in diagnosing, localizing, and/or treating neoplasias. Further provided are methods for treating a neoplastic disease, particularly melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell lung carcinoma.  Patients who are in remission as a result of traditional modes of cancer therapy may be treated with a composition of this invention in hopes of reducing the risk of recurrence.  Patients may also be treated concurrently with the antibodies and traditional anti-neoplastic agents.
Patent NZ-505428-A (NZ)
Title: N-6 heterocyclic substituted adenosine derivatives
Inventor: LUM ROBERT T
IPC: A61P9/00
Filed: 1997-08-20
Abstract: A method for stimulating coronary activity in a non-human mammal experiencing a coronary electrical disorder that can be treated by stimulating the A1 heart adenosine receptor is described. The method involves administering to a non-human mammal an effective amount of a composition comprising the substituted adenosine derivatives of the formula shown wherein: R1 is a substituted or unsubstituted monocyclic ring system containing 3 to 15 atoms with at least one heteroatom chosen from N, O or S(-O)0-2,and wherein R1 is not a monocyclic lactam or imide, and wherein R1 does not contain an epoxide group.
Patent NZ-507029-A (NZ)
Title: Tamper resistant closure and use in medicament inhalation device
Inventor: BRAND PETER JOHN
IPC: A61M15/00
Filed: 1998-01-06
Abstract: A tamper resistant closure of figure 1 is used for closing an opening of a container.  The container defines an outer peripheral wall (97) adjacent the opening and presents at least one inner ledge(98) below the opening. The closure comprises a cylindrical skirt portion (92) having a lip (93).  When assembled the lip (93) forms a snap fit with the ledge(98) to hold the closure in place.  The inner peripheral wall (96) of the container seats against the closure when assembled. This closure may be used in an inhalation device (fig 2), such as that disclosed in NZ patent 336507.
Patent NZ-507848-A (NZ)
Title: Method of increasing the mutation rate of a virus in a non-human by administering an RNA nucleoside analogue to a virally infected cell
Inventor: MULLINS JAMES I
IPC: C12N15/10
Filed: 1997-10-27
Abstract: Described are ribonucleoside analogues that induce the mutation of an RNA virus and used in a method of increasing the mutation rate of a virus in a non-human patient. The method comprises administering a RNA nucleoside analogue to a virally infected cell wherein the analogue is incorporated by a polymerase into an RNA copy of a genomic nucleic acid encoding the virus, the analogue replacing a first naturally occurring nucleotide having a first complementary nucleotide wherein the analogue complements a second nucleotide which is other than the first nucleotide, thereby inhibiting viral replication. (62) Divided out of 335000
Patent NZ-508449-A (NZ)
Title: A wire stainer with spool and pawl
Inventor: TERZAGI ANDRE
IPC: F16G11/12
Filed: 2000-11-27
Abstract: A  wire strainer intended for straining of wire  in  a fence structure is described.  The wire strainer includes  a body  (12)  with  which a spool (11) having a  plurality  of teeth (18) is rotatably mounted.  An engagement member  (21) extends  between and is slidingly engaged in elongate  slots (20).   Legs  (24) of the engagement member  (21)  slidingly engage  with the inside wall surfaces of the divergent  arms (15) pf body (12).  The legs (24) thus apply a force to  the engagement  member (21) so that it engages  with  the  teeth (18).   The  engagement  member (21)  can  be  removed  from contact  with the spool (11) by sliding against the  biasing effect  of the legs (24) so as to engage with the step  (27) in the elongate opening (20).
Patent NZ-510919-A (NZ)
Title: 2,4-disubstituted triazine derivatives
Inventor: VAN AKEN KOEN JEANNE ALFONS
IPC: C07D251/46
Filed: 1999-11-04
Abstract: Described are triazine compounds of formula (I'), wherein: -a1=a2-a3=a4- is a bivalent radical of -CH=CH-CH=CH-, -N=CH- CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, or -N=N-CH=CH-, and the remaining substituents are as defined herein. The compounds are used in the manufacture of medicaments for the treatment of HIV infection.
Patent NZ-512050-A (NZ)
Title: Retroreflective annular beam prism and flow cytometer apparatus
Inventor: SHARPE JOHNATHAN
IPC: G01N21/01
Filed: 1998-02-02
Abstract: A beam of optical radiation from a source 5 is directed onto the apex 2 of the conical portion 3 at the forward end of the prism 1 and in the direction of the central axis of the prism.  The beam is reflected by the reflector 4 provided behind the apex so that the beam is refracted by the prism to project from the forward end of the prism as an annular beam 7.  Alternatively, the prism may have a pyramid shaped front portion with an even number of inclined faces meeting at the apex so that the beam emerging from the front of the prism is in the form of a multisided tube of parallel beams.
Patent NZ-518299-A (NZ)
Title: Ciclesonide-containing aqueous pharmaceutical composition
Inventor: NAGANO ATSUHIRO
IPC: A61K9/51
Filed: 2000-10-20
Abstract: An aqueous pharmaceutical composition which containing ciclesonide and hydroxypropylmethylcellulose. The ciclesonide is dispersed in an aqueous medium in the form of solid particles.
Patent NZ-520784-A (NZ)
Title: Method and composition for protecting plants from disease, using saponin
Inventor: DUTCHESHEN JOSEPH M
IPC: A01N65/00
Filed: 2001-02-15
Abstract: A method of treating a diseased plant or seed. The method comprises contacting least a portion of disease plant or seed with an amount of a composition comprising a triterpene saponin derived from a member selected from the group consisting of Quinoa and Quilaja, to elicit a protective response in said plant or seed. The saponin is the only active ingredient of the composition, such that said plant or seed portion has less than 1 mg of aldehyde groups per square centimeter of plant or seed surface area.
Patent NZ-522791-A (NZ)
Title: Protecting against impulse expenditure including setting rules for expenditure on a portable data storage device
Inventor: ROWAN EARLE GEORGE
IPC: G06Q30/06
Filed: 2001-06-29
Abstract: A method of protecting against impulse expenditure during an expenditure period includes the step prior to the commencement of the expenditure period, of using a digital information-processing device to enter or select rules governing permissible expenditure during the expenditure period. During the expenditure period, expenditure controlling apparatus is used to control expenditure in accordance with the rules defined prior to the commencement of the expenditure period. The rules governing permissible expenditure are stored on a portable data storage device, and the portable data storage device is used to convey the rules to the expenditure controlling apparatus.
Patent NZ-523214-A (NZ)
Title: A dosage form of a solid monolithic matrix non-circular in shape having first and second orthoganal axes of unequal length and that swells upon contact with water
Inventor: BERNER BRET
IPC: A61K9/00
Filed: 2001-02-26
Abstract: Discussed is the retention of oral drug dosage forms in the stomach by using swellable dosage forms that are shaped in a manner that will prevent them from inadvertently passing through the pylorus as a result of being in a particular orientation.  The planar projection of the shape is one that has two orthogonal axes of different lengths, the longer being short enough to permit easy swallowing prior to swelling while the shorter is long enough within one-half hour of swelling to prevent passage through the pylorus.
Patent NZ-525589-A (NZ)
Title: Fibre membrane arrangement
Inventor: PHELPS ROGER
IPC: C02F1/44
Filed: 2001-10-22
Abstract: A method of reducing solids fouling between porous membranes in a membrane filtration system of the type having a plurality of membranes mounted, at least at one end, to a header and operable to withdraw permeate from multicomponent liquid substrate in which said porous membranes are immersed, the method including rendering a portion of one or more of the membranes, adjacent the header, inoperative.
Patent NZ-527078-A (NZ)
Title: Camptothecin 20S ester derivatives and their use in treating cancer
Inventor: YANG LI-XI
IPC: C07D491/22
Filed: 2001-12-20
Abstract: A compound of formula (I) is described wherein wherein R is R1-O-(CH2)m-, m is an integer of 1-10; R1 is phenyl optionally substituted, a fused, 2-, 3-, or 4-ring heterocyclic system optionally substituted, 1-or 2-naphthyl optionally substituted, or a 5 or 6 membered heterocyclic ring containing one or two nitrogen atoms, which ring is optionally substituted; R2 is hydrogen, halo, lower alkyl, lower alkoxy, hydroxy, RC(O)O, cyano, nitro, amino, halogenated lower alkyl, halogenated lower alkoxy, hydroxycarbonyl, formyl, lower alkoxycarbonyl, tri lower alkylsilyl, lower alkylcarbonyloxy, lower alkylcarbonylamino, loweralkylcarbonyloxymethyl, substituted vinyl, 1-hydroxy-2-nitroethyl, alkoxycarbonylethyl, aminocarbonyl, mono-or dialkylcarbonyl, alkylcarbonyloxymethyl, benzoylmethyl,benzylcarbonyloxymethyl, or mono-or di lower alkoxymethyl. R3 is hydrogen, halo, lower alkyl, lower alkoxy, hydroxy, RC(O)O, cyano, nitro, amino, halogenated lower alkyl, halogenated lower alkoxy, hydroxycarbonyl, formyl, lower alkoxycarbonyl, CH2NR7R8 (where each of R7 and R8 is independently H-, alkyl of 1-6 carbons, optionally substituted phenyl, hydroxy lower alkyl, amino lower alkyl, or mono-or dialkylamino lower alkyl, or R7 and R8 taken together with N-represent a cyclic amino-), CH2R9 (where R9 is lower alkoxy, CN, amino lower alkoxy, mono-or di-lower alkylamino lower alkoxy, lower alkylthio, amino lower alkylthio, or mono-or di-lower alkylamino lower alkylthio), or NR10R11 (where each of R10 and R11 is independently hydrogen, lower alkyl, phenyl, hydroxy lower alkyl, amino lower alkyl, or mono-or di-lower alkyl, or R10 and R11 taken together with-N-represent a cyclic amino), dialkylamino alkyl, lower alkylcarbonyloxy, or lower alkylcarbonylamino; and R4 is hydrogen, halo, lower alkyl, lower alkoxy, hydroxy, RC(O)O cyano, nitro, amino, amino lower alkyl, halogenated lower alkyl, halogenated lower alkoxy, hydroxycarbonyl, formyl, lower alkoxycarbonyl, carbamoyloxy, lower alkylcarbonyloxy, or lower alkylcarbonylamino, or R4 together with R5 is methylenedioxy ; R5 is hydrogen, halo, lower alkyl, lower alkoxy, hydroxy, RC (O) O cyano, nitro, amino, halogenated lower alkyl, halogenated lower alkoxy, hydroxycarbonyl, formyl, lower alkoxycarbonyl, lower alkylcarbonyloxy, or lower alkylcarbonylamino; R6 is hydrogen, halo, lower alkyl, lower alkoxy, hydroxy, RC(O)O cyano, nitro, amino, halogenated lower alkyl, halogenated lower alkoxy, hydroxycarbonyl, formyl, lower alkoxycarbonyl, lower alkylcarbonyloxy, or lower alkylcarbonylamino; Pharmaceutical compositions comprising the compounds are useful for the treatment of cancer.
Patent NZ-533721-A (NZ)
Title: Peptides and their use for treating inflammatory conditions
Inventor: HANCOCK ROBERT
IPC: C12Q1/68
Filed: 2002-12-02
Abstract: An isolated peptide comprising the general formula X1X2X3IX4PX4IPX5X2X1 (SEQ ID NO:4), wherein each X1 is individually one or two of R, L or K, each X2 is individually one of C, S or A, X3 is one of R or P, each X4 is individually one of A or V and X5 is one of V or W. Also disclosed is the use of the peptide for treating inflammatory conditions and sepsis.
Patent NZ-534487-A (NZ)
Title: Container and lid with indicator
Inventor: SPENCE DAVID LOUIS
Filed: 2004-08-03
Abstract: A closure for releasably closing a container having a mouth, the closure having a closing portion for closing over the mouth of the container, the closure having a skirt which depends from a periphery of the closing portion, and the skirt having first and second skirt portions which extend about respective portions of the periphery of the closing portion and which are frangibly attached to one another, and the closure having a securing portion at an upper edge of the skirt, the securing portion being configured to be engageable with a complementary securing portion on the container to releasably secure the closure over the mouth of the container.
Patent NZ-535153-A (NZ)
Title: Novel methylated cyclodextrin complexes
Inventor: JARVINEN TOMI
IPC: C08B37/00
Filed: 2003-02-20
Abstract: Complex of a cyclodextrin selected from the group consisting of RM-beta-cyclodextrin, DM-beta-cyclodextrin and TM-beta-cyclodextrin, and a cannabinoid selected from the classical cannabinoid-group consisting of cannabinol, tetrahydrocannabinol and cannabidiol.
Patent NZ-535243-A (NZ)
Title: Method for generating primate trophoblasts
Inventor: XU REN-HE
IPC: A61K38/18
Filed: 2003-03-14
Abstract: A method to induce primate stem cells to differentiate directly into primate trophoblast cells comprising the step of culturing the primate cells in the presence of a protein trophoblast-inducing factor, for example bone morphogenic protein 4 (BMP4), bone morphogenic protein 2 (BMP2), bone morphogenic protein 7 (BMP7), and growth and differentiation factor 5 (GDF5). Also described is a culture of the described primate trophoblast cells in an in vitro culture; and a method of testing agents for their effect on placental cells comprising: creating primate trophoblast cells, exposing the primate trophoblast cells to agent, and observing the effect the agent has on the trophoblast cells.
Patent NZ-537207-A (NZ)
Title: Hyperbranched biodegradable and hydrolysable polymers
Inventor: SODERGARD NIELS DAN ANDERS
IPC: C09D201/00
Filed: 2003-05-30
Abstract: Disclosed herein is a process for preparing a hyperbranched polymer having a weight-average molar mass of at least 30,000, comprising coupling a first prepolymer having at least three functional end groups with a second prepolymer having at least two functional end groups by a dehydration condensation reaction between the end groups in the prepolymers. The number of arms and/or molar mass of the functionalized prepolymers can accurately be adjusted, thus affecting the properties of the resulting hyperbranched polymer in a desired way. Thus the polymer can be equipped e.g. with hydrophobic and hydrophilic parts. Also, the number of functional end groups, that optionally can be used for further chemical reactions, in the hyperbranched polymer can easily be adjusted to a desired level. The hyperbranched high molar mass polymer can be prepared in high yields without the use of organic solvents or linking compounds, which is advantageous from an environmental as well as an economical point of view.
Patent NZ-538097-A (NZ)
Title: Method and compositions for improving wound healing
Inventor: KAMBADUR RAVI
Filed: 2005-02-07
Abstract: A cosmetic method for improving tissue wound healing by reducing scar formation comprises administering a myostatin antagonist. The method is preferably for reducing scar formation of a superficial wound, including cuts and abrasions; deep wounds extending through skin and muscle, including surgical incisions; bruises, hematomas; and burns. Also disclosed is the use of a myostatin antagonist for treating fibrotic disorders such as cystic fibrosis, and other fibrotic disorders characterized by excessive deposition of collagen and fibrotic tissue.
Patent NZ-543764-A (NZ)
Title: Oven with vertically moveable shelf in drawer
Inventor: WILSON GUY EMERSON
Filed: 2005-11-24
Abstract: An oven with a vertically moveable shelf is disclosed. The oven has a drawer located in a heated cabinet. The drawer is able to move to a position partially outside the cabinet when a door (2) is opened. A shelf (10) is located within the drawer and is supported by a framework that controls vertical movement of the shelf.
Patent NZ-545410-A (NZ)
Title: A device for releasable mounting of a bundle of bags on a wall
Inventor: BAROUTA TONY
IPC: B65D33/00
Filed: 2004-08-06
Abstract: A device for releasably mounting a bundle (30) of bags on a wall (2), said device comprising a wall-mounted suspension fitting (1), wherein one rear major surface of the bag bundle is connected to a sheet (40) which is parallel with said bundle and which is adapted for releasable co-action with the fitting (1), and wherein the bags (32) in said bundle are releasably (36) connected to said sheet at there respective opening regions. According to the invention, the sheet has an opening (45) midway of its width and the fitting has upwardly directed clip-finger (11) which includes in an upper portion of its side facing towards the wall (2) a projection (15) that can be received in the opening (45) in the sheet (40), and the projection (15) has two vertically separated oblique surfaces (16, 17) which are mutually convergent in a direction towards said wall for co-action with the upper and lower edges of the sheet opening.
Patent NZ-547673-A (NZ)
Title: Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
Inventor: SCHELLER DIETER
IPC: A61K31/381
Filed: 2004-12-23
Abstract: Disclosed is the use of a tetralin tertiary amine compound of the general formula wherein, n = 1 to 5, R6 and R7 are independently alkyl or aryl, R5 is a alkyl and the further substituents are defined in the specification, wherein the compound of formula I is present as a racemate or as a pure (R)- or (S)-enantiomer as well as physiologically acceptable salts of these compounds, in the manufacture of a medicament or kit for the preventative treatment of Parkinson's disease.
Patent NZ-550831-A (NZ)
Title: 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione or CC-4047 for the treatment and management of myelodysplastic syndromes
Inventor: ZELDIS JEROME B
IPC: A61P7/00
Filed: 2004-04-14
Abstract: Disclosed is the use of 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione or CC-4047 in the manufacture of a composition for treating myelodysplastic syndrome.
Patent NZ-554944-A (NZ)
Title: Methods for preventing and/or extinguishing fires
Inventor: SORTWELL EDWIN T
IPC: A62D1/00
Filed: 2004-11-05
Abstract: Disclosed is a method for applying water-laden polymer particles to a surface to prevent and/or extinguish a fire, the method comprising: a) adding a dispersion comprising a vegetable oil and a dry, ground, cross-linked, water-swellable polymer to water to form a water-additive mixture containing water-laden polymer particles, wherein the polymer holds more than about 50 weight percent (wt.%) of the water in the water-additive mixture after swelling, the oil and the particle size of the polymer being selected to result in the formation of an immobilized gel; and, b) directing the water-additive mixture comprising the immobilized gel onto a surface to prevent and/or extinguish a fire.